Our esteemed speakers
Richard J. Gralla, MD FACP
Director of Oncology Research, Albert Einstein College of Medicine, Jacobi Medical Center, and Professor of Medicine, in New York.
Author or co-author of over 250 scientific articles and book chapters. Board member of the Multinational Association of Supportive Care in Cancer and of the oncology section of the International Society for Chemotherapy. Holds memberships in the American Society of Clinical Oncology, the American Association for Cancer Research, the International Association for the Study of Lung Cancer, and the Oncology Nursing Society. Past-President of the Multinational Association of Supportive Care in Cancer and Past-President of the New York Lung Cancer Alliance.
Athina Vadalouca MD PhD
Associate Professor of Anaesthesia, Pain Relief & Palliative Care, University of Athens ,GREECE; Fellow of Interventional Pain Practice of WIP(FIPP); President of the Hellenic Society of Pain Therapy and Palliative Care; Visiting Prof. of the University of L’Aquila,Italy; Visiting Prof.of the University of Istanbul,Turkey
Matti S. Aapro MD PhD
Clinique de Genolier
Dean of the Multidisciplinary Oncology Institute, Genolier, Switzerland.
He serves the International Society for Geriatric Oncology (SIOG) as Executive Board Member.
He was member of the Board of the European Organization for Research and Treatment of
Cancer (EORTC). He is past-President of the Multinational Association for Supportive Care in
Cancer (MASCC), and is now on its Board of Directors for 2012-2014.
Fausto Roila MD PhD
Director of Medical Oncology, Santa Maria Hospital, Terni, Italy
Member of the Board of the Multinational Association of Supportive Care in Cancer (MASCC)
Member of the Consultant Committee for the Oncological Drugs of the Italian Agency of the Drugs (A.I.F.A.), of the Ethical Committee of Aziende Sanitarie of Umbria and of the Committee of Hospital Therapeutic Formulary of Umbria Region.
Alberto Fusi MD PhD
Charité – Comprehensive Cancer Centre – Berlin, Lead of the Melanoma Clinical Trials Unit
The Christie Hospital NHS Foundation Trust – Manchester, Medical Oncologist working within the Melanoma and Lung Cancer Team
Charitè – Campus Benjamin Franklin – Berlin, Hematology and Oncology Department, Postdoctoral fellow involved in translational research studies and coordination of a side study of the EORTC 18991 trial. Medical oncologist, Lab Team leader for the evaluation and characterization of circulating tumour cells in patients with solid tumours.
Jørn Herrstedt MD DMSc
Chief Consultant and Professor in Clinical Oncology, Section of Gynaecologic Oncology, Department of Oncology, Odense University Hospital, Denmark and the University of Southern Denmark. Head of Research and of the Elite Research Centre, Academy of Geriatric Cancer Research (AgeCare).
Emeritus Professor Sam H Ahmedzai
Emeritus Professor at the Medical School at University of Sheffield, with 30 years’ experience of being consultant physician in palliative medicine. Sam chaired the 2015 UK NICE guideline for care of the dying adult (NG31) and he is clinical advisor to the new NICE guideline committee on service delivery in the last year of life. He is clinical lead for the Royal College of Physicians of London’s national audit of end of life care, published in March 2016. He is NIHR national specialty lead for cancer research outside the acute hospital and chairs the NCRI’s Clinical Studies Group on Supportive and Palliative Care. Sam is editor in chief of ‘Current Opinion in Supportive and Palliative Care’ and of the Oxford Textbook series on ‘Supportive Care’.
Ms Snezana Bosnjak, MD, PhD, Research Professor, Clinical Pharmacologist
Research Professor Snežana Bošnjak, MD, PhD, is a Clinical Pharmacologist in the Supportive Oncology Service at the Institute for Oncology and Radiology of Serbia in Belgrade, Serbia, where she specializes in the pharmacotherapy of symptoms of malignant disease and toxicities induced by anticancer treatment. Dr Bošnjak has long been actively involved in supportive & palliative care education and research, in efforts to improve the availability of essential medications, and in efforts to improve national policy regarding supportive and palliative care. She has been instrumental in introducing the philosophy of supportive oncology in Serbia.
Snežana Šušnjar, MD, PhD
Specialized in internal medicine and work at the Institute for Oncology and Radiology of Serbia, Department for Medical Oncology, Intensive Oncology Care and Supportive Oncology Unit. Member of the Board of Oncology Section of the Serbian Medical Association and Scientific Board of the Institute. Member of the Board of the Serbian Society for Medical Oncology and ESMO national representative since 2014.
